Administrative and Outreach Core
行政和外展核心
基本信息
- 批准号:10697339
- 负责人:
- 金额:$ 78.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-26 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdvisory CommitteesAdvocacyAdvocateAffectArchivesAutomobile DrivingClinicCollaborationsColoradoCommunicationCommunitiesDataData AnalysesData Coordinating CenterDevelopmentDown SyndromeEducationEducational workshopEnsureEventFeedbackGeneral PopulationGoalsGovernmentGovernment OfficialsHuman ResourcesInvestigationLaboratoriesLeadershipMissionModelingPediatric HospitalsPersonsPhiladelphiaPhysiciansPoliciesPopulationProceduresProgress ReportsRegistriesResearch PersonnelResourcesScientistSiteSocietiesSourceSystemTrainingUnited States National Institutes of HealthUniversitiesadvocacy organizationsclinical practicecommunity engagementcomorbiditydata accessdata ecosystemdata managementdata portaldata sharingdesignempowermentevidence basemeetingsonline tutorialoperationoutreachperformance siterecruitsuccesstoolusability
项目摘要
PROJECT SUMMARY – Administrative and Outreach Core.
The key objective of the Administrative and Outreach Core (AOC) of the INCLUDE Data Coordinating Center
(DCC) is to provide the integrated leadership, management, and administrative system required to fulfill the
Center’s mission of serving all people with Down syndrome (DS) by accelerating a vast range of investigations
into mechanisms driving and modulating comorbidities in this population. The AOC will guide and coordinate the
activities of the Data Management Core (DMC) and the Data Portal Core (DPC) to ensure that they meet their
objective of creating a world class resource for broad data sharing, access, and analysis.
Within the AOC, a Project Management Team (PMT) will be assembled with key personnel from three major
performance sites: the Linda Crnic for Down Syndrome at the University of Colorado, the Center for Data Driven
Discovery at Children’s Hospital of Philadelphia, and Sage Bionetworks in Seattle. Using management and
administrative strategies successfully employed in more than a dozen multi-site DCCs, the PMT will ensure
collaborative, synergistic, and mission-aligned action across all DCC teams. The PMT will also ensure that all
activities across the DCC are highly attuned to the needs of the community of stakeholders to be served by the
INCLUDE Data Portal, which will be achieved through an open collaboration model promoting both transparency
in the DCC operations and critical feedback from stakeholders.
A key goal of the AOC is to ensure that the INCLUDE Data Portal empowers not only scientists, but also
physicians, educators, government officials, advocates, and the general public with the data access and analysis
tools required for evidence-based transformative action in the laboratory, the clinic, the classroom, the
government, and society at large. While the primary objective is to accelerate discoveries on the mechanisms
driving comorbidities in DS, the Data Portal could also have broader impacts on clinical practice, education,
policy, and advocacy. Furthermore, it will be important to also engage communities focused on the study of DS
comorbidities in the typical population. Therefore, within the AOC, the Outreach Team will implement a portfolio
of outreach strategies to promote widespread use of the Data Portal and receive critical feedback from a diverse
range of users to guide the evolutionary design of the Portal.
Altogether, the AOC activities will advance the mission of the INCLUDE Project by enabling myriad investigations
of the co-occurring conditions affecting those with trisomy 21, while also ensuring broader use of all data
generated to advance training, education, and advocacy efforts.
项目摘要-行政和外展核心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joaquin M. Espinosa其他文献
Metabolic dysfunction mediated by HIF-1α contributes to epithelial differentiation defects in eosinophilic esophagitis
- DOI:
10.1016/j.jaci.2024.07.030 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Sinéad Ryan;Louise Crowe;Sofía N. Almeida Cruz;Matthew D. Galbraith;Carol O’Brien;Juliet A. Hammer;Ronan Bergin;Shauna K. Kellett;Gary E. Markey;Taylor M. Benson;Olga Fagan;Joaquin M. Espinosa;Niall Conlon;Claire L. Donohoe;Susan McKiernan;Andrew E. Hogan;Eóin N. McNamee;Glenn T. Furuta;Calies Menard-Katcher;Joanne C. Masterson - 通讯作者:
Joanne C. Masterson
Sa1249: ASSESSMENT OF A GENETIC RISK SCORE FOR CELIAC DISEASE IN DOWN SYNDROME
- DOI:
10.1016/s0016-5085(22)60849-7 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Marisa G. Stahl;Jessica R. Shaw;Angela L. Rachubinski;Matthew D. Galbraith;Paul Norman;Sameer Chavan;Laura A. Leaton;Ronald J. Sokol;Edwin Liu;Joaquin M. Espinosa - 通讯作者:
Joaquin M. Espinosa
Joaquin M. Espinosa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joaquin M. Espinosa', 18)}}的其他基金
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
唐氏综合症回归障碍治疗的机制研究
- 批准号:
10701872 - 财政年份:2022
- 资助金额:
$ 78.45万 - 项目类别:
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
唐氏综合症回归障碍治疗的机制研究
- 批准号:
10519053 - 财政年份:2022
- 资助金额:
$ 78.45万 - 项目类别:
A Pilot for Enhancing Support for a Federated Framework of Biospecimens for Down Syndrome Research via the INCLUDE Data Hub
通过 INCLUDE 数据中心加强对唐氏综合症研究生物样本联合框架的支持的试点
- 批准号:
10671310 - 财政年份:2020
- 资助金额:
$ 78.45万 - 项目类别:
Interferon hyperactivity, COVID19, and Down syndrome
干扰素过度活跃、新冠肺炎 (COVID19) 和唐氏综合症
- 批准号:
10215951 - 财政年份:2020
- 资助金额:
$ 78.45万 - 项目类别:
Understanding Down Syndrome as an Interferonopathy
将唐氏综合症理解为一种干扰素病
- 批准号:
9892863 - 财政年份:2019
- 资助金额:
$ 78.45万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 78.45万 - 项目类别:
Standard Grant